Press releases
- Abcam appoints Markus Lusser as new President
- Danaher Commits to Set Science-Based, Net-Zero Greenhouse Gas Emission Reduction Targets
- Danaher Launches Collaboration with Cincinnati Children's Hospital Medical Center Aiming to Improve Patient Safety in Early Drug Development
- Danaher Reports Fourth Quarter and Full Year 2023 Results
- Danaher, Jennifer Doudna, and Innovative Genomics Institute Launch Danaher-IGI Beacon for CRISPR Cures with Aim to Address Hundreds of Diseases Using Gene-editing Platform Solution
- Danaher CEO to Comment on Financial Performance
More ▼
Key statistics
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.00 |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | 292.38 |
Average volume | -- |
---|---|
Shares outstanding | -- |
Free float | -- |
P/E (TTM) | -- |
Market cap | -- |
EPS (TTM) | -- |
Data delayed at least 20 minutes, as of Jun 29 2022 12:30 BST.
More ▼